title: Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
abstract: Contrast-induced nephropathy (CIN) is associated with increased morbidity, extended hospital stay, and higher costs. We compared an atorvastatin plus N-acetylcysteine (NAC) regimen with NAC alone in patients undergoing coronary angiography. A total of 130 patients (mean age 54 +/- 10; 77 men) undergoing coronary angiography were studied. Seven CIN cases occurred in the NAC group and 2 in the atorvastatin + NAC group; this difference was not significant. Baseline mean creatinine and estimated glomerular filtration rate (eGFR) were similar between the 2 groups, whereas after the procedure there was a significant creatinine decrease and eGFR increase in the atorvastatin + NAC group. Change in creatinine (baseline creatinine-creatinine after the procedure) was also significantly higher in patients taking statin plus NAC. Atorvastatin may be effective in protecting patients undergoing coronary angiography from CIN.
authors.affiliation: Department of Cardiology, Duzce University Düzce Medical School, Konuralp Düzce, Turkey. ozhanhakan@yahoo.com
authors.forename: Hakan
authors.initials: H
authors.lastname: Ozhan
authors.forename: Ismail
authors.initials: I
authors.lastname: Erden
authors.forename: Serkan
authors.initials: S
authors.lastname: Ordu
authors.forename: Mesut
authors.initials: M
authors.lastname: Aydin
authors.forename: Onur
authors.initials: O
authors.lastname: Caglar
authors.forename: Cengiz
authors.initials: C
authors.lastname: Basar
authors.forename: Subhan
authors.initials: S
authors.lastname: Yalcin
authors.forename: Recai
authors.initials: R
authors.lastname: Alemdar
mesh_terms: D000111:Acetylcysteine / Q000008:administration & dosage; D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control*; D000328:Adult; D000069059:Atorvastatin; D003287:Contrast Media / Q000009:adverse effects*; D017023:Coronary Angiography; D003404:Creatinine / Q000097:blood; D005260:Female; D005919:Glomerular Filtration Rate; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000008:administration & dosage*
chemical_list: D003287:Contrast Media; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D003404:Creatinine; D000111:Acetylcysteine